Creative Medical Technology Holdings, Inc. Common Stock
CELZCreative Medical Technology Holdings, Inc. (CELZ) is a biotechnology company focused on developing regenerative medicine therapies, particularly in the field of stem cell and regenerative medicine. The company aims to create innovative solutions for medical conditions through the application of cellular technology and regenerative approaches.
Company News
Creative Medical Technology Holdings announced promising mid-term follow-up data from its StemSpine® pilot study, which demonstrated a substantial reduction in opioid dependency and significant improvements in pain levels and functional mobility for chronic lower back pain patients.
PHOENIX, June 24, 2024 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (“Creative Medical Technology” or the “Company”) (NASDAQ: CELZ), a leading commercial stage biotechnology company focused on a regenerative approach to immunotherapy, urology, neurology, and orthopedics, today announced that it has successfully generat...
Shares of HighPeak Energy, Inc. (NASDAQ: HPK) fell sharply during Thursday’s session after the company reported worse-than-expected fourth-quarter revenue results. HighPeak Energy posted GAAP earnings of 66 cents per share, versus market estimates of 65 cents per share. The company’s quarterly sales came in at $301.153 million versus expecta...
Creative Medical's (CELZ) CELZ-101 gets FDA's Orphan Drug designation for preventing allograft rejection in type-I diabetes patients undergoing pancreatic islet cell transplantation. Stock rises.
Here is how Aurinia Pharmaceuticals (AUPH) and Creative Medical Technology Holdings, Inc. (CELZ) have performed compared to their sector so far this year.
